Patent · US Active

Substituted isoquinolinones and methods of treatment thereof

US9115141B2 · kind B2 · utility

25Cited by

154References

49Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Tao Liu · Shanghai, CN
Daniel A. Snyder · Somerville, US
Martin Tremblay · Waltham, US
Pingda Ren · San Diego, US
Yi Liu · San Diego, US
Liansheng Li · San Diego, US
Katrina Chan · Fremont, US

Key dates

Filing date	Dec 6, 2013
Grant date	Aug 25, 2015
Priority date	—
Expiry date	Dec 6, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted isoquinolinone compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.